Desenfriol-D is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Salimex, S.a.. The primary component is Chlorpheniramine Maleate; Phenylephrine Hydrochloride; Acetaminophen.
| Product ID | 53666-517_5bed9460-0223-127c-e053-2991aa0a8ae0 |
| NDC | 53666-517 |
| Product Type | Human Otc Drug |
| Proprietary Name | Desenfriol-D |
| Generic Name | Chlorpheniramine Maleate, Phenylephrine Hydrochloride, Acetaminophen |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-10-18 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Salimex, S.A. |
| Substance Name | CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN |
| Active Ingredient Strength | 0 g/g; g/g; g/g |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2017-10-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2017-10-18 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-03-02 |
| Ingredient | Strength |
|---|---|
| CHLORPHENIRAMINE MALEATE | .001 g/g |
| SPL SET ID: | 5bed9460-0222-127c-e053-2991aa0a8ae0 |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 53666-417 | Desenfriol-D | CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN |
| 53666-517 | Desenfriol-D | CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN |
| 53666-617 | Desenfriol-D | CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DESENFRIOL-D 78929863 not registered Dead/Abandoned |
Schering Corporation 2006-07-14 |
![]() DESENFRIOL-D 73158265 1101928 Dead/Cancelled |
SCHERING CORPORATION 1978-02-10 |